Fundraising Fox

Overjet

Boston, US · Founded 2018 · 13 known investors

Overjet builds FDA-cleared AI software for dental practices and payers, including x-ray analysis that detects disease and anatomy, AI-native imaging software, automated insurance verification, and voice-based clinical documentation. Its product suite serves dental organizations, providers, and insurers to support diagnosis, workflow automation, and revenue cycle performance.

Also known as Overjet, Inc.

Founders & leadership

Overjet was founded in 2018 by Wardah Inam.

WI
Wardah InaminFounder

Board

LJLonne Jaffe
Lonne Jaffein𝕏Board directorManaging Director at Insight Partners
JMJames Montgomery
James MontgomeryinBoard directorCo-Founder & Managing Partner at March Capital Partners
CBChris Bischoff
Chris Bischoffin𝕏Board directorInvestment Team at General Catalyst
HHHabib Haddad
Habib Haddadin𝕏Board directorManaging Partner at The E14 Fund
PBPhil Boyer
Phil Boyerin𝕏Board directorPartner at Crosslink Capital
DR
Deepak RamaswamyBoard director

Investors · 13

Also in the syndicate · 4

American Dental AssociationLiquid 2 VenturesMarch CapitalleadSpring Rock Capital

Reported raises · per SEC filings

Form D private placements

$117.2M disclosed across 5 of 6 rounds · 2020–2025

$24.6MraisedDec 2025 · 22 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Lonne JaffeDirector
  • Wardah InamExecutive Officer, Director
  • Chris BischoffDirector
  • James MontgomeryDirector
Offering amount
$34.8M
Amount sold
$24.6M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$800KraisedDec 2025 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Lonne JaffeDirector
  • James MontgomeryDirector
  • Chris BischoffDirector
  • Wardah InamExecutive Officer, Director
Offering amount
$800K
Amount sold
$800K
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$56.7MraisedMar 2024 · 18 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Wardah InamExecutive Officer, Director
  • James MontgomeryDirector
  • Lonne JaffeDirector
  • Chris BischoffDirector
Offering amount
$56.7M
Amount sold
$56.7M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$27.2MraisedAug 2021 · 12 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Deepak RamaswamyDirector
  • Phil BoyerDirector
  • Chris BischoffDirector
  • Wardah InamExecutive Officer, Director
Offering amount
$27.3M
Amount sold
$27.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$7.8MraisedApr 2020 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wardah InamExecutive Officer, Director
  • Habib HaddadDirector
  • Phil BoyerDirector
  • Deepak RamaswamyDirector
Offering amount
$7.8M
Amount sold
$7.8M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$550Mvaluation at Series CMar 2024
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Company profile

researched Aug 2026

Overjet is a Boston-based dental artificial intelligence company that develops software for dentists, dental support organizations (DSOs), dental schools and insurers. Its core technology analyzes dental X-rays to detect, outline and quantify oral disease and anatomy; the company states its platform is FDA-cleared and describes it as the only technology cleared by the U.S. Food and Drug Administration to detect, outline and quantify instances of oral disease with millimeter-level precision. The models are trained on millions of cases and accuracy is verified by a team of clinical specialists; across multiple FDA studies, the company reports that almost every general dentist tested was more accurate in detecting cavities and calculus when using Overjet.

The product suite includes Vision AI for radiographic disease and anatomy detection and patient communication, IRIS, an AI-native dental imaging application that auto-populates images into templates and enhances them without cloud storage fees, an automated dental insurance verification product that verifies patient coverage days in advance and returns code-level coverage breakdowns through integrations with more than 1,000 payers, and a Voice AI suite that combines imaging insights with real-time voice documentation, automated charting and visit summaries. Overjet also offers pediatric-focused functionality referenced as Overjet for Kids, and works with dental schools including the University of Florida College of Dentistry and WesternU College of Dental Medicine.

On the payer side, Overjet automates the manual review of dental insurance claims, which the company positions as creating a shared, objective interpretation of radiographs between providers, insurers and patients. The company's stated longer-term goal is a unified standard, or "operating system," connecting diagnosis and treatment with claim review and benefits decisions.

Founding story

Overjet was founded in 2018 when computer scientists from MIT and dentists from Harvard came together to build dental AI, and was incubated at the Harvard Innovation Labs. Cofounder and CEO Wardah Inam holds master's and doctoral degrees in electrical engineering and computer science from MIT and a bachelor's degree from the Ghulam Ishaq Khan Institute of Engineering Sciences and Technology in Pakistan; she previously was lead product manager at Q Bio and founded uLink. Cofounder and CTO Deepak Ramaswamy also holds a PhD from MIT and had more than seventeen years of experience in computational science; COO Shaju Puthussery, a Boston College graduate, was previously Chief Analytics Officer at DentaQuest.

Business model

Overjet sells AI software to dental providers (individual practices and DSOs), dental education institutions and dental insurance payers, with distinct product lines for clinical imaging, imaging software, insurance verification and voice documentation.

The company markets separate product lines to providers, educators and insurers; sources describe the offerings and buyer segments but do not detail pricing or contract structure.

Traction

At the time of its Series C, Overjet reported serving thousands of dentists across private practices and the largest DSOs in North America and partnering with payers covering more than 120 million members, including the majority of the 10 biggest U.S. dental insurers. Customers cited include Jefferson Dental, Dental Care Alliance, Aligned Dental Partners, Mortenson Dental Partners, CORDENTAL Group and Rodeo Dental & Orthodontics, plus dental schools at the University of Florida and WesternU.

Latest developments

Recent company blog items describe the launch of hard tissue charting and natural voice periodontal charting that completes the chart in real time as providers speak, and IRIS being positioned as the only FDA-cleared AI system for dental image quality checks. The company also promotes an AI Summit in Scottsdale held September 22-24.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

Overjet describes itself as the world leader in dental AI, and its Series C was characterized as the largest investment in artificial intelligence for dentistry at the time. Investor March Capital described the company as the market leader in the dental AI category. The company has been recognized on the Forbes AI 50, Fast Company's World's Most Innovative Companies and Built In's Best Places to Work.

The company positions FDA clearance for detecting, outlining and quantifying oral disease as a differentiator, along with visualization that highlights decay rather than bounding it in boxes, AI built natively into its imaging software rather than added on, and a single platform spanning both provider clinical workflows and payer claim review.

Technology

Deep learning models analyze dental radiographs to identify oral anomalies such as tooth decay, calculus and bone loss, outlining and quantifying findings with stated millimeter-level precision. Outputs feed a dashboard that aggregates insights for dental organizations, an AI-native imaging application (IRIS), automated insurance verification integrated with over 1,000 payers, and a voice suite that produces structured clinical documentation. The company states its AI augments rather than replaces human judgment, with all treatment and benefits decisions made by accredited professionals.

Go-to-market

Overjet uses a direct sales motion supported by demo requests and a free trial for Vision AI on its website, customer testimonials from practices and DSOs, and industry events such as its AI Summit in Scottsdale. In 2024 the company added go-to-market leadership including a VP of Customer Success for Practice, an SVP of Marketing and an SVP of Revenue.

Dentists in private practice, dental support organizations, dental schools and residency programs, and dental insurance payers, including the majority of the 10 largest U.S. dental insurers.

Geography

Headquartered at 200 State St, Suite 1220, Boston, Massachusetts, with customers described as spanning private practices and the largest DSOs in North America.

History

Founded in 2018 and incubated at the Harvard Innovation Lab, Overjet was profiled by Forbes in March 2020 for applying AI to dental care, with an early product centered on a dashboard aggregating deep learning insights from clinical data for DSOs and automated claims analysis for insurers. By 2023 it had raised nearly $80 million and its CEO was ranked #35 on the Boston Globe Tech Power Players 50. In March 2024 it announced a $53.2 million Series C at a $550 million valuation, bringing total funding to roughly $133 million, and it has since expanded into AI-native imaging (IRIS), automated insurance verification and voice-based clinical documentation.

Risks & controversies

Overjet's platform informs insurer claim review as well as clinical diagnosis, a dual role that depends on regulatory clearance; the company emphasizes that its AI augments rather than replaces human judgment and that all treatment and benefits decisions remain with accredited professionals.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Payer integrations for insurance verificationJan 20251,000 payers
Payer members covered by partner insurersMar 2024120,000,000 members
Total funding raisedJan 2025$130M
ValuationMar 2024$550M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 1

by search overlap

Companies competing with Overjet for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 7

launches, deals, and filings
Aug 2026
Launch of hard tissue charting and natural voice perio

Overjet launched hard tissue charting and natural voice periodontal charting, allowing providers to speak naturally while the chart completes in real time.

source ↗

Aug 2026
IRIS becomes the only FDA-cleared AI system for dental image quality checks

source ↗

Mar 2024
Recognition on Forbes AI 50, Fast Company Most Innovative Companies and Built In Best Places to Work

source ↗

Mar 2024
Overjet announces $53.2 million Series C at $550 million valuation

Series C led by March Capital with participation from General Catalyst, Insight Partners, E14 Fund, Crosslink Capital, Spring Rock Capital, Liquid 2 Ventures, Harmonic Growth Partners and the American Dental Association, bringing total funding to about $133 million.

$53.2M source ↗

Mar 2024
Go-to-market executives added

Overjet added Mike Lemire as VP of Customer Success for Practice, Mario Paganini as SVP of Marketing and Matthew Ewing as SVP of Revenue.

source ↗

Jan 2023
CEO Wardah Inam ranked #35 on Boston Globe Tech Power Players 50

Inam was also appointed in 2023 to the board of advisers of the Workman School of Dental Medicine at High Point University.

source ↗

Jan 2022
CEO Wardah Inam named to Inc.'s top 100 female founders list

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Overjet do?
Overjet builds FDA-cleared dental AI for X-ray analysis, imaging, insurance verification and voice documentation for providers and payers.
Who founded Overjet?
Overjet was founded by Wardah Inam in 2018.
Who are Overjet's investors?
Overjet's investors include Crosslink Capital, General Catalyst, Harmonic Growth Partners, Insight Partners, March Capital Partners, SPRINGROCK VENTURES, The E14 Fund, Blumberg Capital and 1 more.
How much funding has Overjet raised?
Overjet has disclosed $117.2M raised across 5 of its 6 known rounds.
Where is Overjet headquartered?
Overjet is headquartered in Boston, US.